AbbVie
ABBV
#33
Rank
S$465.29 B
Marketcap
S$263.06
Share price
-2.23%
Change (1 day)
5.86%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): S$8.55 Billion

According to AbbVie's latest financial reports the company's current earnings are S$61.16 Billion. , an increase over its 2024 earnings that were of S$4.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 S$8.39 B77.53%
2024 S$4.73 B-40.54%
2023 S$7.95 B-53.62%
2022 S$17.16 B3.76%
2021 S$16.53 B282.25%
2020 S$4.32 B-59.67%
2019 S$10.72 B62.13%
2018 S$6.61 B-32.74%
2017 S$9.83 B-1.99%
2016 S$10.03 B18.65%
2015 S$8.46 B180.5%
2014 S$3.01 B-55.57%
2013 S$6.78 B-6.86%
2012 S$7.28 B56.05%
2011 S$4.67 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$12.97 B 54.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$32.76 B 290.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.42 B 36.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$1.98 B-76.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$12.47 B 48.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$11.87 B 41.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$17.96 B 113.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$12.60 B 50.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$0.81 B-90.35%๐Ÿ‡บ๐Ÿ‡ธ USA